688P - Prognostic impact of KRAS mutation in metastatic (met) pancreatic cancer patients (pts)

Autor: Verdaguer, H., Sauri, T., Ruiz, F., Vivancos, A., Nuciforo, P., Capdevila, J., Elez, E., Alsina, M., Martinez, G. Argiles, Hierro, C., Grasselli, J., Matos, I., Tabernero, J., Dienstmann, R., Macarulla, T.
Zdroj: In Annals of Oncology 1 October 2016 27 Supplement 6:vi232-vi232
Databáze: ScienceDirect